Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Victorian Clinical Genetics Services, |
RCV000656739 | SCV002766769 | pathogenic | Coffin-Siris syndrome 6 | 2020-06-11 | criteria provided, single submitter | clinical testing | Based on the classification scheme VCGS_Germline_v1.1.1, this variant is classified as pathogenic. Following criteria are met: 0102 - Loss-of-function is a known mechanism of disease for this gene. (N) 0107 - This gene is known to be associated with autosomal dominant disease. (N) 0201 - Variant is predicted to cause nonsense-mediated decay (NMD) and loss of protein (exon 15 of 21). (P) 0251 - Variant is heterozygous. (N) 0301 - Variant is absent from gnomAD. (P) 0701 - Comparable variants also predicted to result in an NMD predicted protein, have very strong previous evidence for pathogenicity (Decipher, PMID:30838730). (P) 0803 - Low previous evidence of pathogenicity in an individual with Coffin-Siris syndrome (ClinVar). (P) 0905 - No segregation evidence has been identified for this variant. (N) 1007 - No published functional evidence has been identified for this variant. (N) 1208 - Inheritance information for this variant is not currently available. (N) Legend: (P) - Pathogenic, (N) - Neutral, (B) - Benign |
Foundation for Research in Genetics and Endocrinology, |
RCV000656739 | SCV000778312 | pathogenic | Coffin-Siris syndrome 6 | 2018-05-09 | no assertion criteria provided | clinical testing | The observed variant c.2521C>T (p.Gln841Ter) is not reported in 1000 Genomes and ExAC databases. The in silico prediction of the variant is disease causing by MutationTaster2. |